HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
HN 11501
thromboxane A2 receptor antagonist
Also Known As:
((5-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)-2-thienyl)oxy)acetic acid; HN-11501; HN11501
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amides: 2428
Sulfonamides: 2809
HN 11501: 1
Sulfur Compounds: 278
Sulfones: 534
Sulfonamides: 2809
HN 11501: 1
Thiophenes: 257
HN 11501: 1
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Thiophenes: 257
HN 11501: 1
Related Diseases
1.
Thrombosis (Thrombus)
01/01/1992 - "
The strongest additive thrombosis-inhibiting effect was observed after oral administration of HN-11501 at a dose of 2.5 mg/kg together with an intravenous infusion of 1 microgram/kg/h of a prostacyclin analogue (cicaprost).
"
01/01/1992 - "
The antithrombotic effect of a thromboxane A2 receptor antagonist (HN-11501:5-[2-(4-chlorophenylsulfonylamino)-ethyl]-2-thienylox y-acetic acid) alone and in combination with other antithrombotic agents has been studied in an experimental thrombosis model in which laser lesions are used to induce a defined thrombosis in rat mesenteric venules.
"
Related Drugs and Biologics
1.
Prostaglandin H2 Thromboxane A2 Receptors
2.
Acetic Acid (Vinegar)
3.
Epoprostenol (Prostacyclin)
4.
Fibrinolytic Agents (Antithrombotic Agents)
5.
cicaprost
Related Therapies and Procedures
1.
Lasers (Laser)
2.
Intravenous Infusions
3.
Oral Administration